학술자료 2025-10-11 23:15:51

초기 알츠하이머병 환자에 대한 L-세린의 효과 연구

Phase IIa L-serine Trial for eAD (LSPI-2)

내용

  • This is a Phase IIa, randomized, double-blind, placebo controlled trial.
  • Subjects for participation in this study will be identified by the Investigator based on their Clinical Dementia Rating score which will be completed as part of standard practice.
  • Patients meeting the criteria for early Alzheimer's disease will be considered for study participation, with the Investigator taking the additional inclusion/exclusion criteria into consideration.
  • Up to 40 subjects will be enrolled.
  • Subjects participating in the study will be randomized to receive either gummies containing L-Serine or placebo gummies, with the Investigator and study staff blinded to the group assignments.

요약

  • This is a Phase IIa, randomized, double-blind, placebo controlled trial.
  • Subjects for participation in this study will be identified by the Investigator based on their Clinical Dementia Rating score which will be completed as part of standard practice.
  • Patients meeting the criteria for early Alzheimer's disease will be considered for study participation, with the Investigator taking the additional inclusion/exclusion criteria into consideration.
  • Up to 40 subjects will be enrolled.
  • Subjects participating in the study will be randomized to receive either gummies containing L-Serine or placebo gummies, with the Investigator and study staff blinded to the group assignments.

결과 해석 : 연구적 관점

  • This page reorganizes publicly available research into a reference summary focused on possible functional relevance.
  • Because the source is study-specific, it is useful for understanding the reported findings in context.
  • Human data, when present, can inform applicability more directly.
  • Functional interpretation should remain cautious because outcomes depend on design, population, and study conditions.
  • It is reasonable to interpret the findings together with the broader body of evidence.

결과 해석 : 과학적 관점

  • Single studies offer design clarity, but reproducibility still matters.
  • Human studies improve applicability, but sample size and comparator design remain important.
  • Interpretation should remain conservative when endpoints are limited or follow-up is short.
  • Confidence improves when findings are consistent with related papers.
  • Overall, this material is best used as a research reference rather than as a definitive functional claim.

안내

본 페이지는 공개논문, 특허, 학술자료를 바탕으로 재작성한 참고용 자료입니다.
특정 제품의 예방 또는 치료 효능을 의미하지 않습니다.